Prospera Financial Services Inc increased its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 16.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,972 shares of the conglomerate’s stock after acquiring an additional 684 shares during the quarter. Prospera Financial Services Inc’s holdings in Danaher were worth $983,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of DHR. Pacific Capital Partners Ltd bought a new position in Danaher during the first quarter valued at about $7,175,000. CWM LLC grew its holdings in shares of Danaher by 36.9% during the 1st quarter. CWM LLC now owns 30,811 shares of the conglomerate’s stock worth $6,316,000 after purchasing an additional 8,313 shares in the last quarter. MQS Management LLC bought a new stake in shares of Danaher during the first quarter valued at approximately $225,000. Sigma Planning Corp increased its position in shares of Danaher by 10.1% during the first quarter. Sigma Planning Corp now owns 11,279 shares of the conglomerate’s stock valued at $2,312,000 after purchasing an additional 1,036 shares during the period. Finally, Wealthfront Advisers LLC raised its stake in shares of Danaher by 8.6% in the first quarter. Wealthfront Advisers LLC now owns 58,503 shares of the conglomerate’s stock valued at $11,993,000 after purchasing an additional 4,645 shares in the last quarter. 79.05% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at $552,352.50. The trade was a 66.34% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 11.20% of the company’s stock.
Danaher Price Performance
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s dividend payout ratio is presently 26.39%.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the stock. Cowen reissued a “buy” rating on shares of Danaher in a report on Wednesday, October 22nd. Robert W. Baird set a $247.00 target price on shares of Danaher in a research report on Wednesday, October 22nd. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a research note on Thursday, October 23rd. Rothschild Redb cut shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $243.39.
Read Our Latest Analysis on Danaher
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Best Stocks Under $10.00
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
